NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Cancer of the Breast
Interventions: DEVICE: VENTANA MIB-1 Ki67 assay|DEVICE: Oncotype DX® Recurrence Score|DEVICE: PAM50-based Prosigna breast cancer gene signature assay|DRUG: Anastrozole|DRUG: Combination anthracycline and/or taxane based treatment
Sponsor: Washington University School of Medicine
Collaborators: Swim Across America|The Foundation for Barnes-Jewish Hospital